SS
IBB icon

SBI Securities’s iShares Biotechnology ETF IBB Stock Holding History

SBI Securities’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$293K Sell
1,540
-570
-27% -$98K 0.01% 551
2026
Q1 		$356K Sell
2,110
-33
-2% -$5.64K 0.01% 481
2025
Q4 		$362K Buy
2,143
+23
+1% +$3.74K 0.01% 464
2025
Q3 		$306K Buy
2,120
+182
+9% +$24.8K 0.01% 507
2025
Q2 		$245K Sell
1,938
-260
-12% -$31.9K 0.01% 526
2025
Q1 		$281K Buy
2,198
+108
+5% +$14.6K 0.01% 447
2024
Q4 		$276K Buy
+2,090
New +$294K 0.01% 461

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

SBI Securities's IBB Position: Q2 2026 in Review

SBI Securities reduced its iShares Biotechnology ETF (IBB) stake by 27% in Q2 2026, selling an estimated $98K and leaving 1,540 shares worth $293K. The position accounts for 0.01% of the portfolio, ranked #551.

SBI Securities first reported a position in IBB in Q4 2024 and has held it in 7 quarters since. The position peaked at $362K in Q4 2025. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • SBI Securities held 1,540 shares of iShares Biotechnology ETF worth $293K as of Q2 2026.
  • SBI Securities sold 570 iShares Biotechnology ETF shares in Q2 2026, an estimated $98K.
  • iShares Biotechnology ETF made up 0.01% of SBI Securities's portfolio in Q2 2026, its #551 holding.
  • SBI Securities first reported a position in iShares Biotechnology ETF in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's iShares Biotechnology ETF position peaked at $362K in Q4 2025.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.